A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 (Vesleteplirsen) in Patients With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT03375255 · COMPLETED
Trial details
- NCT number
- NCT03375255
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-05
- Primary completion
- 2019-08-19
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.